Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $641.35 | 39 | 95.5% |
| Education | $29.99 | 1 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $158.46 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $108.33 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $70.44 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $67.56 | 5 | $0 (2018) |
| Novo Nordisk Inc | $59.58 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $45.85 | 3 | $0 (2019) |
| Lilly USA, LLC | $36.83 | 3 | $0 (2019) |
| Amgen Inc. | $35.38 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $26.50 | 2 | $0 (2017) |
| Shire North American Group Inc | $18.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $11.74 | 1 | Novo Nordisk Inc ($11.74) |
| 2019 | $257.18 | 13 | Janssen Pharmaceuticals, Inc ($70.44) |
| 2018 | $177.15 | 11 | Allergan Inc. ($86.16) |
| 2017 | $225.27 | 15 | SANOFI-AVENTIS U.S. LLC ($44.48) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Diabetes | ||||||
| 12/16/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Respiratory | ||||||
| 12/12/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Bone Health | ||||||
| 10/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 10/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Respiratory | ||||||
| 07/12/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/13/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $70.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2019 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Diabetes | ||||||
| 02/04/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2018 | Philips Electronics North America Corporation | Wellcentive Undiv (Device) | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 10/01/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: DIABETES | ||||||
| 08/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: DIABETES | ||||||
| 05/17/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/13/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/08/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 385 | 684 | $89,565 | $33,165 |
| 2022 | 8 | 472 | 868 | $113,640 | $45,489 |
| 2021 | 11 | 617 | 979 | $142,440 | $57,202 |
| 2020 | 10 | 415 | 742 | $92,523 | $28,758 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 160 | 299 | $37,076 | $16,011 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 204 | $36,720 | $13,190 | 35.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 13 | 57 | $6,555 | $2,416 | 36.9% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 11 | 56 | $4,760 | $1,198 | 25.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 34 | 51 | $1,632 | $200.94 | 12.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $2,822 | $149.63 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 190 | 387 | $48,044 | $21,949 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 239 | $43,020 | $16,759 | 39.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 16 | 67 | $7,705 | $2,886 | 37.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 13 | 28 | $4,648 | $1,717 | 36.9% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 11 | 39 | $3,315 | $1,011 | 30.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $1,552 | $683.75 | 44.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 43 | 74 | $2,368 | $293.76 | 12.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 18 | $2,988 | $189.25 | 6.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 228 | 428 | $53,072 | $25,174 | 47.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 228 | $41,040 | $18,935 | 46.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $13,464 | $2,616 | 19.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 14 | 56 | $6,440 | $2,478 | 38.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 12 | 34 | $5,644 | $2,471 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $3,680 | $2,134 | 58.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 51 | 51 | $10,914 | $1,928 | 17.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 17 | $1,649 | $726.88 | 44.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 49 | 72 | $2,304 | $289.44 | 12.6% |
| 86318 | Test for detection of infectious agent antibody, qualitative or semiquantitative | Office | 2021 | 15 | 15 | $1,245 | $271.35 | 21.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 18 | $2,988 | $179.25 | 6.0% |
About Dr. Martha Turner, M.D
Dr. Martha Turner, M.D is a General Practice healthcare provider based in Riverton, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902809130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martha Turner, M.D has received a total of $671.34 in payments from pharmaceutical and medical device companies, with $11.74 received in 2020. These payments were reported across 40 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($641.35).
As a Medicare-enrolled provider, Turner has provided services to 1,889 Medicare beneficiaries, totaling 3,273 services with total Medicare billing of $164,615. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties General Practice
- Location Riverton, WY
- Active Since 05/23/2005
- Last Updated 01/30/2025
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1902809130
Products in Payments
- JANUVIA (Drug) $108.33
- VRAYLAR (Drug) $88.45
- XARELTO (Drug) $70.44
- TOUJEO (Drug) $55.47
- VIBERZI (Drug) $37.79
- TRULICITY (Drug) $36.83
- Ozempic (Drug) $32.02
- BREO (Drug) $26.50
- SYMBICORT (Drug) $24.24
- FARXIGA (Drug) $21.61
- Prolia (Biological) $19.81
- BYSTOLIC (Drug) $18.49
- GATTEX (Drug) $18.09
- SPIRIVA RESPIMAT (Drug) $16.92
- Victoza (Drug) $16.90
- ENTRESTO (Drug) $16.24
- EVENITY (Biological) $15.57
- LINZESS (Drug) $13.73
- SOLIQUA (Drug) $12.09
- Wellcentive Undiv (Device) $11.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Riverton
Dr. Jeremy Thompson, Dds, DDS
General Practice — Payments: $16,066
Dr. Richard Shulze, D.m.d, D.M.D
General Practice — Payments: $7,076
Dr. Daniel Hauck, Dds, DDS
General Practice — Payments: $3,010
Scott Lewis, D.m.d, D.M.D
General Practice — Payments: $1,663
Jeffrey Hanzon, D.m.d, D.M.D
General Practice — Payments: $480.69
Dr. James Mcfarlane, D.d.s, D.D.S
General Practice — Payments: $417.31